What is AURX's current stock price?

AURX (Nuo Therapeutics, Inc.) is currently trading at $0.99 with a market cap of $47.9M.

What sector is Nuo Therapeutics, Inc. in?

Nuo Therapeutics, Inc. (AURX) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

AURX Nuo Therapeutics, Inc.

OTCHealthcare

$0.9900-3.88%ClosedMarket Cap: $47.9M

As of 2026-05-29 16:00

Latest News

Nuo Therapeutics Announces First Quarter 2026 Financial Results and Provides Business UpdateGlobeNewsWire · 2026-05-14

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

OTC

Beta

-104.09

Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing primarily in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was founded in 1998 and is based in Houston, Texas.